title: Cystic fibrosis bone disease: is the CFTR corrector C18 an option for therapy?
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Velard
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France.
authors.forename: Martial
authors.initials: M
authors.lastname: Delion
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France.
authors.forename: Flora
authors.initials: F
authors.lastname: Lemaire
authors.affiliation: Inserm U938, Hospital St-Antoine, Paris, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Tabary
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France.
authors.forename: Christine
authors.initials: C
authors.lastname: Guillaume
authors.affiliation: Département de Chirurgie Thoracique, Hôpital Européen Georges Pompidou, Paris, France.
authors.forename: Françoise
authors.initials: F
authors.lastname: Le Pimpec Barthès
authors.affiliation: Inserm U874, Unité de Défense Innée et Inflammation, Institut Pasteur, Paris, France.
authors.forename: Lhousseine
authors.initials: L
authors.lastname: Touqui
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France.
authors.forename: Sophie
authors.initials: S
authors.lastname: Gangloff
authors.affiliation: Unité de Pneumo-Pédiatrie Allergologie, Hôpital Necker, Inserm U1551, Université Paris Sorbonne, Paris, France.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Sermet-Gaudelus
authors.affiliation: EA 4691 «Biomatériaux et Inflammation en site osseux», SFR CAP-Santé (FED 4231), Université Reims Champagne-Ardenne, Reims, France jacky.jacquot@inserm.fr.
authors.forename: Jacky
authors.initials: J
authors.lastname: Jacquot
mesh_terms: D000293:Adolescent; D000328:Adult; D015519:Bone Density / Q000187:drug effects / Q000235:genetics; D001847:Bone Diseases / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology; D003550:Cystic Fibrosis / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D019005:Cystic Fibrosis Transmembrane Conductance Regulator / Q000235:genetics / Q000378:metabolism; D006801:Humans; D008297:Male; D009154:Mutation; D012307:Risk Factors; D052416:Targeted Gene Repair / Q000379:methods*
chemical_list: D019005:Cystic Fibrosis Transmembrane Conductance Regulator